Literature DB >> 7519998

Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies.

J Hasbold1, C Johnson-Léger, C J Atkins, E A Clark, G G Klaus.   

Abstract

We describe here the derivation of a rat monoclonal antibody (mAb) against mouse CD40 (designated 3/23), which stains 45-50% of spleen cells of adult mice, approximately 90% of which are B cells. Interestingly, some 5-10% of both CD4+ and CD8+ T cells in the spleens of (some, but not all) adult, unimmunized mice are also CD40+, whereas CD40+ cells were not detectable in the thymus, even following collagenase digestion. Some 35-40% of lymphoid cells in the bone marrow of adult mice are CD40+ and virtually all of these are B220+, and hence of the B cell lineage: triple-color flow cytometry showed that CD40 is expressed at low levels on some 30% of pre-B cells, at intermediate levels on 80% of immature B cells and on essentially all mature B cells in the bone marrow. These results, therefore, suggest that in the mouse CD40 is expressed relatively late during the process of B cell differentiation. The mAb induced marked up-regulation of major histocompatibility complex class II molecules, CD23 and B7.2 antigens on mature B cells. It also stimulated modest levels of DNA synthesis in mature B cells by itself: this was markedly enhanced by suboptimal concentrations of mitogenic (but not non-mitogenic) anti-mu and anti-delta mAb, and moderately enhanced by co-stimulation with interleukin-4. Hypercross-linking of CD40 (using biotinylated mAb and avidin) also enhanced the proliferative response to anti-CD40.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519998     DOI: 10.1002/eji.1830240817

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

1.  Immunohistowax processing, a new fixation and embedding method for light microscopy, which preserves antigen immunoreactivity and morphological structures: visualisation of dendritic cells in peripheral organs.

Authors:  B Pajak; T De Smedt; V Moulin; C De Trez; R Maldonado-López; G Vansanten; E Briend; J Urbain; O Leo; M Moser
Journal:  J Clin Pathol       Date:  2000-07       Impact factor: 3.411

2.  Properties of mouse CD40: differential expression of CD40 epitopes on dendritic cells and epithelial cells.

Authors:  T K Van Den Berg; J Hasbold; C Renardel De Lavalette; E A Döpp; C D Dijkstra; G G Klaus
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

Review 3.  T-cell-independent antitumor effects of CD40 ligation.

Authors:  Alexander L Rakhmilevich; Kory L Alderson; Paul M Sondel
Journal:  Int Rev Immunol       Date:  2012-08       Impact factor: 5.311

4.  Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.

Authors:  Chongmin Huan; Matthew L Kelly; Ryan Steele; Iuliana Shapira; Susan R S Gottesman; Christopher A J Roman
Journal:  Nat Immunol       Date:  2006-08-27       Impact factor: 25.606

5.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

6.  The fate of effector CD8 T cells in vivo is controlled by the duration of antigen stimulation.

Authors:  Xiaopei Huang; Yiping Yang
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

7.  Rewiring of CD40 is necessary for delivery of rescue signals to B cells in germinal centres and subsequent entry into the memory pool.

Authors:  K Siepmann; J Skok; D van Essen; M Harnett; D Gray
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

8.  Ligation of CD40 with soluble CD40 ligand reverses anti-immunoglobulin-mediated negative signalling in murine B lymphoma cell lines but not in immature B cells from neonatal mice.

Authors:  S Marshall-Clarke; G Owen; L Tasker
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

9.  Regulation of interleukin-6 and interleukin-6R alpha (gp80) expression by murine immunoglobulin-secreting B-cell hybridomas.

Authors:  T Iwasaki; T Hamano; J Fujimoto; E Kakishita
Journal:  Immunology       Date:  1998-04       Impact factor: 7.397

10.  Regulation of cytokine expression by an autoreactive B cell clone derived from MRL/MP-lpr/lpr mice.

Authors:  T Iwasaki; T Hamano; J Fujimoto; A Ogata; E Kakishita
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.